Antigen Information
General Information of This Antigen
Antigen ID | TAR0ZHRFU |
|||||
---|---|---|---|---|---|---|
Antigen Name | Glutamate carboxypeptidase 2 (FOLH1) |
|||||
Gene Name | FOLH1 |
|||||
Gene ID | ||||||
Synonym | Cell growth-inhibiting gene 27 protein; Folate hydrolase 1; Folylpoly-gamma-glutamate carboxypeptidase; Glutamate carboxypeptidase II; Membrane glutamate carboxypeptidase; N-acetylated-alpha-linked acidic dipeptidase I; Prostate-specific membrane antigen; Pteroylpoly-gamma-glutamate carboxypeptidase |
|||||
Sequence |
MWNLLHETDSAVA.RPRWLCAGALVLAGGFFLLGFLFGWFIKSSNEATNITPKHNMKAFL
DELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNK THPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYART EDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSY PDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDA QKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTL RGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWD AEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELK SPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWE TNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAV VLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLR MMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPS KAWGEVKRQIYVAAFTVQAAAETLSEVA Click to Show/Hide
|
|||||
Family | Peptidase M28 family |
|||||
Function |
Has both folate hydrolase and N-acetylated-alpha-linked- acidic dipeptidase (NAALADase) activity. Has a preference for tri- alpha-glutamate peptides. In the intestine, required for the uptake of folate. In the brain, modulates excitatory neurotransmission through the hydrolysis of the neuropeptide, N-aceylaspartylglutamate (NAAG), thereby releasing glutamate. Involved in prostate tumor progression.; Also exhibits a dipeptidyl-peptidase IV type activity. In vitro, cleaves Gly-Pro-AMC.
Click to Show/Hide
|
|||||
Uniprot Entry | ||||||
HGNC ID | ||||||
KEGG ID |
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
7E11 C5
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
Monoclonal antibody 7E11 C5-selenocystamine conjugate |
Undisclosed |
Undisclosed |
Undisclosed |
[1] |
Anti-PSMA IgG1 mAb D2B
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
111In-DTPA-D2B-DAR4-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[2] | |
111In-DTPA-D2B-DAR2-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[2] |
Anti-PSMA mAb
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
PSMA-15 |
DM1 derivative 15 |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[3] | |
PSMA-16 |
DM1 derivative 16 |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[3] |
Anti-PSMA mAb 5D3
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
111In-DOTA-5D3 |
Indium-111 |
Human Deoxyribonucleic acid (hDNA) |
Tetraxetan |
[4] |
Anti-PSMA mAb D2B
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
D2B-DCM |
Duocarmycin A |
Human Deoxyribonucleic acid (hDNA) |
Mc-Val-Cit-PABC |
[5] |
Anti-PSMA mAb h3/F11-Var16
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
h3/F11-Var16 (Anti-PSMA)-30.2060 |
Amanitin 30.206 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
[6] | |
h3/F11-Var16 (Anti-PSMA)-30.2867 |
Amanitin 30.2867 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Maleimido-caproyl |
[6] |
Anti-PSMA mAb hD7-1
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
hD7-1 (VL-VH)-PE24mut |
Pseudomonas exotoxin PE24 mut |
Eukaryotic elongation factor 2 (EEF2) |
Undisclosed |
[7] | |
hD7-1 (VL-VH)-PE40 |
Pseudomonas exotoxin PE40 |
Eukaryotic elongation factor 2 (EEF2) |
Undisclosed |
[7] | |
hD7-1 (VL-VH)-PE24 |
Pseudomonas exotoxin PE24 |
Eukaryotic elongation factor 2 (EEF2) |
Undisclosed |
[7] |
Anti-PSMA mAb wt
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
SYD998 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] | |
WO2015177360A1 ADC-wt-vcMMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[8] | |
WO2015177360A1 ADC-wt-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[8] |
Anti-PSMA mAb wt HC A339C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-HC339 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt HC D376C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-HC376 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt HC E152C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-HC152 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt HC G236C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-HC236 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt HC P153C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-HC153 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt HC P247C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-HC247 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt HC S375C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-HC375 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt HC S41C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
SYD1091 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] | |
WO2015177360A1 ADC-HC41-vcMMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[8] | |
WO2015177360A1 ADC-HC41-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[8] |
Anti-PSMA mAb wt HC S41C/S375C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-HC41-375 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt HC S41C/T120C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-HC41-120 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt HC T120C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
SYD1035 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt LC E165C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-LC205 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt LC G157C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-LC157 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt LC G41C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-LC41 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] | |
WO2015177360A1 ADC-LC41-vcMMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[8] | |
WO2015177360A1 ADC-LC41-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[8] |
Anti-PSMA mAb wt LC L154C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-LC165 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt LC P40C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-LC154 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] | |
WO2015177360A1 ADC-LC40-vcMMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[8] | |
WO2015177360A1 ADC-LC40-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[8] |
Anti-PSMA mAb wt LC T109C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-LC109 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA mAb wt LC V205C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015177360A1 ADC-LC40 |
seco-DUBA |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer |
[8] |
Anti-PSMA scFv
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
124I-scFvD2B |
Iodine I-124 |
Undisclosed |
Undisclosed |
[9] |
Anti-PSMA-D265C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
Anti-PSMA-D265C-30.2060 |
Amanitin 30.206 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
[6] | |
Anti-PSMA-D265C-30.2115 |
Amanitin 30.2115 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
[6] | |
Anti-PSMA-D265C-30.2347 |
Amanitin 30.2347 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
[6] | |
Anti-PSMA-D265C-30.1699 |
Amanitin 30.1699 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
[6] | |
Anti-PSMA-D265C-30.2371 |
Amanitin 30.2371 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mc-Val-Ala-PABC |
[6] | |
Anti-PSMA-D265C-30.0880 |
Amanitin 30.088 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Maleimido-caproyl |
[6] | |
Anti-PSMA-D265C-30.2867 |
Amanitin 30.2867 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Maleimido-caproyl |
[6] |
Fully human IgG1 Anti-PSMA mAb
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
PSMA-ADC |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[10] |
J591
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
MEDI-3726 |
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG8-Val-Ala-PABC |
[11] |
J591-SC239C
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
PSMA-D Antibody-Compound (X) |
PSMA-D Antibody-Compound (X) payload |
Undisclosed |
PSMA-D Antibody-Compound (X) linker |
[12] | |
PSMA-D Antibody-Compound (XI) |
PSMA-D Antibody-Compound (XI) payload |
Undisclosed |
PSMA-D Antibody-Compound (XI) linker |
[12] | |
PSMA-D Antibody-Compound (XIV) |
PSMA-D Antibody-Compound (XIV) payload |
Undisclosed |
PSMA-D Antibody-Compound (XIV) linker |
[12] | |
PSMA-D Antibody-Compound (XVIII) |
PSMA-D Antibody-Compound (XVIII) payload |
Undisclosed |
PSMA-D Antibody-Compound (XVIII) linker |
[12] | |
PSMA-D Antibody-Compound (Ie) |
PSMA-D Antibody-Compound (Ie) payload |
Undisclosed |
PSMA-D Antibody-Compound (Ie) linker |
[12] | |
PSMA-D Antibody-Compound (XIX) |
PSMA-D Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-D Antibody-Compound (XIX) linker |
[12] | |
PSMA-D Antibody-Compound (Ii) |
PSMA-D Antibody-Compound (Ii) payload |
Undisclosed |
PSMA-D Antibody-Compound (Ii) linker |
[12] | |
PSMA-D Antibody-Compound (XLI) |
PSMA-D Antibody-Compound (XLI) payload |
Undisclosed |
PSMA-D Antibody-Compound (XLI) linker |
[12] | |
PSMA-D Antibody-Compound (XVI) |
PSMA-D Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-D Antibody-Compound (XIX) linker |
[12] | |
PSMA-D Antibody-Compound (XL) |
PSMA-D Antibody-Compound (XL) payload |
Undisclosed |
PSMA-D Antibody-Compound (XL) linker |
[12] | |
PSMA-D Antibody-Compound (XLII) |
PSMA-D Antibody-Compound (XLII) payload |
Undisclosed |
PSMA-D Antibody-Compound (XLII) linker |
[12] | |
J591-SC239C-Compound (XV) |
J591-SC239C-Compound (XV) payload |
Undisclosed |
J591-SC239C-Compound (XV) linker |
[12] | |
PSMA-D Antibody-Compound (XLIII) |
PSMA-D Antibody-Compound (XLIII) payload |
Undisclosed |
PSMA-D Antibody-Compound (XLIII) linker |
[12] |
MLN591
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
MLN2704 |
Mertansine DM1 |
Microtubule (MT) |
Thiopentanoate linker |
[13] |
PSMA-A Anti-ody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
PSMA-A Antibody-Compound (X) |
PSMA-A Antibody-Compound (X) payload |
Undisclosed |
PSMA-A Antibody-Compound (X) linker |
[12] | |
PSMA-A Antibody-Compound (XI) |
PSMA-A Antibody-Compound (XI) payload |
Undisclosed |
PSMA-A Antibody-Compound (XI) linker |
[12] | |
PSMA-A Antibody-Compound (XIV) |
PSMA-A Antibody-Compound (XIV) payload |
Undisclosed |
PSMA-A Antibody-Compound (XIV) linker |
[12] | |
PSMA-A Antibody-Compound (XVIII) |
PSMA-A Antibody-Compound (XVIII) payload |
Undisclosed |
PSMA-A Antibody-Compound (XVIII) linker |
[12] | |
PSMA-A Antibody-Compound (Ie) |
PSMA-A Antibody-Compound (Ie) payload |
Undisclosed |
PSMA-A Antibody-Compound (Ie) linker |
[12] | |
PSMA-A Antibody-Compound (XIX) |
PSMA-A Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-A Antibody-Compound (XIX) linker |
[12] | |
PSMA-A Antibody-Compound (Ii) |
PSMA-A Antibody-Compound (Ii) payload |
Undisclosed |
PSMA-A Antibody-Compound (Ii) linker |
[12] | |
PSMA-A Antibody-Compound (XLI) |
PSMA-A Antibody-Compound (XLI) payload |
Undisclosed |
PSMA-A Antibody-Compound (XLI) linker |
[12] | |
PSMA-A Antibody-Compound (XVI) |
PSMA-A Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-A Antibody-Compound (XIX) linker |
[12] | |
PSMA-A Antibody-Compound (XL) |
PSMA-A Antibody-Compound (XL) payload |
Undisclosed |
PSMA-A Antibody-Compound (XL) linker |
[12] | |
PSMA-A Antibody-Compound (XLII) |
PSMA-A Antibody-Compound (XLII) payload |
Undisclosed |
PSMA-A Antibody-Compound (XLII) linker |
[12] | |
PSMA-A Antibody-Compound (XV) |
PSMA-A Antibody-Compound (XV) payload |
Undisclosed |
PSMA-A Antibody-Compound (XV) linker |
[12] | |
PSMA-A Antibody-Compound (XLIII) |
PSMA-A Antibody-Compound (XLIII) payload |
Undisclosed |
PSMA-A Antibody-Compound (XLIII) linker |
[12] |
PSMA-B Anti-ody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
PSMA-B Antibody-Compound (X) |
PSMA-B Antibody-Compound (X) payload |
Undisclosed |
PSMA-B Antibody-Compound (X) linker |
[12] | |
PSMA-B Antibody-Compound (XI) |
PSMA-B Antibody-Compound (XI) payload |
Undisclosed |
PSMA-B Antibody-Compound (XI) linker |
[12] | |
PSMA-B Antibody-Compound (XIV) |
PSMA-B Antibody-Compound (XIV) payload |
Undisclosed |
PSMA-B Antibody-Compound (XIV) linker |
[12] | |
PSMA-B Antibody-Compound (XVIII) |
PSMA-B Antibody-Compound (XVIII) payload |
Undisclosed |
PSMA-B Antibody-Compound (XVIII) linker |
[12] | |
PSMA-B Antibody-Compound (Ie) |
PSMA-B Antibody-Compound (Ie) payload |
Undisclosed |
PSMA-B Antibody-Compound (Ie) linker |
[12] | |
PSMA-B Antibody-Compound (XIX) |
PSMA-B Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-B Antibody-Compound (XIX) linker |
[12] | |
PSMA-B Antibody-Compound (Ii) |
PSMA-B Antibody-Compound (Ii) payload |
Undisclosed |
PSMA-B Antibody-Compound (Ii) linker |
[12] | |
PSMA-B Antibody-Compound (XLI) |
PSMA-B Antibody-Compound (XLI) payload |
Undisclosed |
PSMA-B Antibody-Compound (XLI) linker |
[12] | |
PSMA-B Antibody-Compound (XVI) |
PSMA-B Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-B Antibody-Compound (XIX) linker |
[12] | |
PSMA-B Antibody-Compound (XL) |
PSMA-B Antibody-Compound (XL) payload |
Undisclosed |
PSMA-B Antibody-Compound (XL) linker |
[12] | |
PSMA-B Antibody-Compound (XLII) |
PSMA-B Antibody-Compound (XLII) payload |
Undisclosed |
PSMA-B Antibody-Compound (XLII) linker |
[12] | |
PSMA-B Antibody-Compound (XV) |
PSMA-B Antibody-Compound (XV) payload |
Undisclosed |
PSMA-B Antibody-Compound (XV) linker |
[12] | |
PSMA-B Antibody-Compound (XLIII) |
PSMA-B Antibody-Compound (XLIII) payload |
Undisclosed |
PSMA-B Antibody-Compound (XLIII) linker |
[12] |
PSMA-C Anti-ody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
PSMA-C Antibody-Compound (X) |
PSMA-C Antibody-Compound (X) payload |
Undisclosed |
PSMA-C Antibody-Compound (X) linker |
[12] | |
PSMA-C Antibody-Compound (XI) |
PSMA-C Antibody-Compound (XI) payload |
Undisclosed |
PSMA-C Antibody-Compound (XI) linker |
[12] | |
PSMA-C Antibody-Compound (XIV) |
PSMA-C Antibody-Compound (XIV) payload |
Undisclosed |
PSMA-C Antibody-Compound (XIV) linker |
[12] | |
PSMA-C Antibody-Compound (XVIII) |
PSMA-C Antibody-Compound (XVIII) payload |
Undisclosed |
PSMA-C Antibody-Compound (XVIII) linker |
[12] | |
PSMA-C Antibody-Compound (Ie) |
PSMA-C Antibody-Compound (Ie) payload |
Undisclosed |
PSMA-C Antibody-Compound (Ie) linker |
[12] | |
PSMA-C Antibody-Compound (XIX) |
PSMA-C Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-C Antibody-Compound (XIX) linker |
[12] | |
PSMA-C Antibody-Compound (Ii) |
PSMA-C Antibody-Compound (Ii) payload |
Undisclosed |
PSMA-C Antibody-Compound (Ii) linker |
[12] | |
PSMA-C Antibody-Compound (XLI) |
PSMA-C Antibody-Compound (XLI) payload |
Undisclosed |
PSMA-C Antibody-Compound (XLI) linker |
[12] | |
PSMA-C Antibody-Compound (XVI) |
PSMA-C Antibody-Compound (XIX) payload |
Undisclosed |
PSMA-C Antibody-Compound (XIX) linker |
[12] | |
PSMA-C Antibody-Compound (XL) |
PSMA-C Antibody-Compound (XL) payload |
Undisclosed |
PSMA-C Antibody-Compound (XL) linker |
[12] | |
PSMA-C Antibody-Compound (XLII) |
PSMA-C Antibody-Compound (XLII) payload |
Undisclosed |
PSMA-C Antibody-Compound (XLII) linker |
[12] | |
PSMA-C Antibody-Compound (XV) |
PSMA-C Antibody-Compound (XV) payload |
Undisclosed |
PSMA-C Antibody-Compound (XV) linker |
[12] | |
PSMA-C Antibody-Compound (XLIII) |
PSMA-C Antibody-Compound (XLIII) payload |
Undisclosed |
PSMA-C Antibody-Compound (XLIII) linker |
[12] |
Rosopatamab
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
Rosopatamab tetraxetan |
Y90 (Radioactive isotope) |
Undisclosed |
Tetraxetan |
[14] |
Undisclosed
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
HDP-103 |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Undisclosed |
[15] | |
DAN-405 |
Cabazitaxel |
Microtubule (MT) |
Undisclosed |
[16] | |
Anti-PSMA antibody-drug conjugate (Protanbio) |
Undisclosed |
Undisclosed |
Undisclosed |
[17] | |
PSMA ADC (Jiangsu hengrui) |
Undisclosed |
Undisclosed |
Undisclosed |
[18] | |
Anti-PSMA antibody-deBouganin fusion protein (Crescendo/Sesen Bio) |
Undisclosed |
Undisclosed |
Undisclosed |
[19] | |
MMAE.VC.SA.617 |
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
[20] | |
Anti-PSMA antibody-drug conjugate |
Undisclosed |
Undisclosed |
Undisclosed |
[21] | |
CB-108 |
Undisclosed |
Undisclosed |
Undisclosed |
[22] |
Tissue/Disease specific Abundances of This Antigen
Tissue specific Abundances of This Antigen
ICD Disease Classification 01
Bacterial infection [ICD-11: 1A00-1C4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gingival | |
The Specific Disease | Bacterial infection of gingival | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.249838229; Fold-change: -0.00877963; Z-score: -0.021889 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 02
Brain cancer [ICD-11: 2A00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Brainstem | |
The Specific Disease | Glioma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.096826132; Fold-change: -0.310740876; Z-score: -3.221302421 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | White matter | |
The Specific Disease | Glioma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 3.10E-05; Fold-change: -2.979089199; Z-score: -2.551172216 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Brainstem | |
The Specific Disease | Neuroectodermal tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 7.86E-09; Fold-change: -1.662248488; Z-score: -5.929405602 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Nervous | |
The Specific Disease | Brain cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.70E-33; Fold-change: -0.61194288; Z-score: -0.798812922 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic myeloid leukemia [ICD-11: 2A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Polycythemia vera | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.001010549; Fold-change: 0.051048264; Z-score: 0.369624587 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Whole blood | |
The Specific Disease | Myelofibrosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 2.09E-06; Fold-change: 0.151595017; Z-score: 0.951000097 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
MyeloDysplastic syndromes [ICD-11: 2A37]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Myelodysplastic syndromes | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.570117985; Fold-change: -0.018537427; Z-score: -0.059519519 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.391151262; Fold-change: -0.077430161; Z-score: -0.523411826 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lymphoma [ICD-11: 2A90- 2A85]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Tonsil | |
The Specific Disease | Lymphoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.991740481; Fold-change: 0.045826995; Z-score: 0.314889352 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Gastric cancer [ICD-11: 2B72]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gastric | |
The Specific Disease | Gastric cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.979364998; Fold-change: -0.11747071; Z-score: -0.314138082 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.21E-05; Fold-change: 0.228501408; Z-score: 1.254505971 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Colon cancer [ICD-11: 2B90]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Colon | |
The Specific Disease | Colon cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.31E-08; Fold-change: 0.110268843; Z-score: 0.440829751 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.232960679; Fold-change: -0.014418156; Z-score: -0.044730924 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pancreatic cancer [ICD-11: 2C10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pancreas | |
The Specific Disease | Pancreatic cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.006754183; Fold-change: -0.308951815; Z-score: -0.813276667 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.000129794; Fold-change: -0.385634438; Z-score: -0.345385456 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Liver cancer [ICD-11: 2C12]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Liver cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.05E-05; Fold-change: -0.403450792; Z-score: -0.661469795 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.19E-05; Fold-change: -0.119658023; Z-score: -0.342709861 | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.086034272; Fold-change: -0.285334233; Z-score: -1.097146733 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lung cancer [ICD-11: 2C25]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Lung cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.015792328; Fold-change: 0.028381216; Z-score: 0.1033747 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.52E-08; Fold-change: 0.089010334; Z-score: 0.42900282 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Melanoma [ICD-11: 2C30]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Melanoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.027391774; Fold-change: 0.86210157; Z-score: 0.882284737 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sarcoma [ICD-11: 2C35]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Sarcoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 3.41E-09; Fold-change: 0.09214561; Z-score: 0.419226668 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.088551002; Fold-change: -0.172232972; Z-score: -1.214646909 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Breast cancer [ICD-11: 2C60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Breast | |
The Specific Disease | Breast cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 6.62E-19; Fold-change: -0.228680422; Z-score: -0.491123174 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.003843658; Fold-change: -0.169896035; Z-score: -0.49235945 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ovarian cancer [ICD-11: 2C73]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Ovarian | |
The Specific Disease | Ovarian cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.113655822; Fold-change: -0.187295983; Z-score: -0.832702695 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.585731932; Fold-change: -0.254759947; Z-score: -0.890184685 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Cervical cancer [ICD-11: 2C77]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Cervical | |
The Specific Disease | Cervical cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.195559494; Fold-change: -0.149953683; Z-score: -0.492204851 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Uterine cancer [ICD-11: 2C78]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Endometrium | |
The Specific Disease | Uterine cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 6.39E-08; Fold-change: -0.34946057; Z-score: -0.83976276 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.079631242; Fold-change: 0.145631797; Z-score: 0.540877282 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Prostate cancer [ICD-11: 2C82]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Prostate | |
The Specific Disease | Prostate cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.40E-09; Fold-change: 2.075991168; Z-score: 2.207145965 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Bladder cancer [ICD-11: 2C94]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bladder | |
The Specific Disease | Bladder cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 9.97E-09; Fold-change: 1.146565091; Z-score: 7.224479893 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Retina cancer [ICD-11: 2D02]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Uvea | |
The Specific Disease | Retinoblastoma tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.10E-07; Fold-change: -0.455828885; Z-score: -3.170301208 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Thyroid cancer [ICD-11: 2D10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Thyroid | |
The Specific Disease | Thyroid cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 2.96E-08; Fold-change: 0.219047778; Z-score: 0.767679927 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.151476383; Fold-change: 0.082023481; Z-score: 0.258114041 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Adrenal cancer [ICD-11: 2D11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Adrenal cortex | |
The Specific Disease | Adrenocortical carcinoma | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.410664414; Fold-change: 9.94E-05; Z-score: 0.001480263 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Head and neck cancer [ICD-11: 2D42]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Head and neck | |
The Specific Disease | Head and neck cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.00414592; Fold-change: -0.061330166; Z-score: -0.247066784 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pituitary cancer [ICD-11: 2F37]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pituitary | |
The Specific Disease | Pituitary gonadotrope tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.447616605; Fold-change: -0.165320148; Z-score: -0.529651608 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Pituitary | |
The Specific Disease | Pituitary cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.479672363; Fold-change: 0.095868977; Z-score: 0.289201596 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 03
Thrombocytopenia [ICD-11: 3B64]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Thrombocytopenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.128678186; Fold-change: 0.052720069; Z-score: 0.451625936 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 04
Lupus erythematosus [ICD-11: 4A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Lupus erythematosus | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.037282829; Fold-change: 0.070101445; Z-score: 0.14465812 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Autoimmune disease [ICD-11: 4A4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral monocyte | |
The Specific Disease | Autoimmune uveitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.755078416; Fold-change: 0.080376245; Z-score: 0.240440156 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 05
Hyperlipoproteinaemia [ICD-11: 5C80]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Familial hypercholesterolemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.368485796; Fold-change: -0.174194657; Z-score: -0.811465957 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 06
Schizophrenia [ICD-11: 6A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Superior temporal cortex | |
The Specific Disease | Schizophrenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.685815693; Fold-change: -0.022433484; Z-score: -0.12448102 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 08
Multiple sclerosis [ICD-11: 8A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Spinal cord | |
The Specific Disease | Multiple sclerosis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.026135578; Fold-change: -0.302510192; Z-score: -1.380010032 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Plasmacytoid dendritic cells | |
The Specific Disease | Multiple sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.568562127; Fold-change: -0.029925823; Z-score: -0.147390282 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Epilepsy [ICD-11: 8A60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peritumoral cortex | |
The Specific Disease | Epilepsy | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.468469261; Fold-change: -0.154281991; Z-score: -0.556977739 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Cerebral ischaemic stroke [ICD-11: 8B11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Cardioembolic Stroke | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000134177; Fold-change: -0.311489351; Z-score: -1.142208278 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Peripheral blood | |
The Specific Disease | Ischemic stroke | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.288832525; Fold-change: 0.026312297; Z-score: 0.154763556 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 1
HIV [ICD-11: 1C60-1C62]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | White matter | |
The Specific Disease | HIV | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.886264273; Fold-change: -0.101277997; Z-score: -0.307974414 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Influenza [ICD-11: 1E30]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Influenza | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.49905218; Fold-change: 0.116483995; Z-score: 0.450255789 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic hepatitis C [ICD-11: 1E51.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Chronic hepatitis C | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.069161059; Fold-change: 0.143720708; Z-score: 0.834491174 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sepsis [ICD-11: 1G40-1G41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Sepsis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.109576669; Fold-change: 0.067875553; Z-score: 0.255904434 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Septic shock [ICD-11: 1G41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Septic shock | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 4.34E-06; Fold-change: 0.192879144; Z-score: 0.58846754 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pediatric respiratory syncytial virus infection [ICD-11: CA40.11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Pediatric respiratory syncytial virus infection | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.63003871; Fold-change: -0.019564358; Z-score: -0.118415074 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 11
Essential hypertension [ICD-11: BA00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Essential hypertension | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.070264574; Fold-change: -0.220696969; Z-score: -2.304229763 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myocardial infarction [ICD-11: BA41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Myocardial infarction | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.333424478; Fold-change: 0.176539723; Z-score: 0.208508726 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Coronary artery disease [ICD-11: BA8Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Coronary artery disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.634386765; Fold-change: -0.036825257; Z-score: -0.174896193 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Aortic stenosis [ICD-11: BB70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Calcified aortic valve | |
The Specific Disease | Aortic stenosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.744603375; Fold-change: 0.2163258; Z-score: 0.309289134 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arteriosclerosis [ICD-11: BD40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arteriosclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.75755819; Fold-change: -0.029523339; Z-score: -0.240233629 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Aneurysm [ICD-11: BD50]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Intracranial artery | |
The Specific Disease | Aneurysm | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.400176687; Fold-change: 0.089490213; Z-score: 0.288049817 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 12
Immunodeficiency [ICD-11: 4A00-4A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Immunodeficiency | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.686583846; Fold-change: 0.020437627; Z-score: 0.201477545 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Apnea [ICD-11: 7A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Hyperplastic tonsil | |
The Specific Disease | Apnea | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.977384748; Fold-change: -0.183272691; Z-score: -0.500718405 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Olive pollen allergy [ICD-11: CA08.00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Olive pollen allergy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.294616274; Fold-change: 0.041153475; Z-score: 0.146825583 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic rhinosinusitis [ICD-11: CA0A]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Sinus mucosa | |
The Specific Disease | Chronic rhinosinusitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.159824677; Fold-change: 0.132661974; Z-score: 0.734525216 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic obstructive pulmonary disease [ICD-11: CA22]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Chronic obstructive pulmonary disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.01460039; Fold-change: 0.157826177; Z-score: 0.644900651 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Small airway epithelium | |
The Specific Disease | Chronic obstructive pulmonary disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.929659249; Fold-change: -0.020737966; Z-score: -0.066430891 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Asthma [ICD-11: CA23]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Nasal and bronchial airway | |
The Specific Disease | Asthma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000731507; Fold-change: -0.191861749; Z-score: -0.194341433 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Human rhinovirus infection [ICD-11: CA42]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Nasal Epithelium | |
The Specific Disease | Human rhinovirus infection | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.365399979; Fold-change: 0.06628046; Z-score: 0.316351433 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Idiopathic pulmonary fibrosis [ICD-11: CB03.4]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Idiopathic pulmonary fibrosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.346173915; Fold-change: -0.100033947; Z-score: -0.339626333 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 13
Periodontal disease [ICD-11: DA0C]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gingival | |
The Specific Disease | Periodontal disease | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.038484715; Fold-change: 0.097508092; Z-score: 0.234246456 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Eosinophilic gastritis [ICD-11: DA42.2]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gastric antrum | |
The Specific Disease | Eosinophilic gastritis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.572886838; Fold-change: 0.036495697; Z-score: 0.175130212 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Liver failure [ICD-11: DB99.7-DB99.8]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Liver failure | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.002655423; Fold-change: 0.275372702; Z-score: 2.073906804 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ulcerative colitis [ICD-11: DD71]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Colon mucosal | |
The Specific Disease | Ulcerative colitis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.9310993; Fold-change: -0.033342569; Z-score: -0.103119127 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Irritable bowel syndrome [ICD-11: DD91.0]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Rectal colon | |
The Specific Disease | Irritable bowel syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.791275166; Fold-change: 0.082156317; Z-score: 0.169981755 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 14
Atopic dermatitis [ICD-11: EA80]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Atopic dermatitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.112255346; Fold-change: 0.074736406; Z-score: 0.326300353 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Psoriasis [ICD-11: EA90]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Psoriasis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 9.87E-07; Fold-change: 0.222316539; Z-score: 0.707128102 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 9.54E-15; Fold-change: 0.563055396; Z-score: 1.158212728 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Vitiligo [ICD-11: ED63.0]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Vitiligo | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.618036859; Fold-change: 0.030257251; Z-score: 0.059323873 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Alopecia [ICD-11: ED70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin from scalp | |
The Specific Disease | Alopecia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.179172525; Fold-change: 0.11706516; Z-score: 0.259325218 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sensitive skin [ICD-11: EK0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Sensitive skin | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.947985327; Fold-change: -0.100299384; Z-score: -0.71130584 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 15
Osteoarthritis [ICD-11: FA00-FA0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Synovial | |
The Specific Disease | Osteoarthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.977542363; Fold-change: -0.011290647; Z-score: -0.064645517 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arthropathy [ICD-11: FA00-FA5Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arthropathy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.156469445; Fold-change: 0.068639543; Z-score: 0.399670876 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arthritis [ICD-11: FA20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.662418918; Fold-change: -0.032565498; Z-score: -0.122118824 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Rheumatoid arthritis [ICD-11: FA20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Synovial | |
The Specific Disease | Rheumatoid arthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.783912884; Fold-change: 0.109323559; Z-score: 0.26258022 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ankylosing spondylitis [ICD-11: FA92.0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pheripheral blood | |
The Specific Disease | Ankylosing spondylitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.478849046; Fold-change: -0.073387902; Z-score: -0.335159638 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Osteoporosis [ICD-11: FB83]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Osteoporosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.896294496; Fold-change: -0.057871945; Z-score: -0.400777863 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 16
Endometriosis [ICD-11: GA10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Endometrium | |
The Specific Disease | Endometriosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.997905875; Fold-change: -0.060686388; Z-score: -0.178552465 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Interstitial cystitis [ICD-11: GC00.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bladder | |
The Specific Disease | Interstitial cystitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.41752326; Fold-change: -0.036931716; Z-score: -0.313013849 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 19
Preterm birth [ICD-11: KA21.4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Myometrium | |
The Specific Disease | Preterm birth | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.609407244; Fold-change: -0.138138524; Z-score: -0.474153284 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 2
Acute myelocytic leukemia [ICD-11: 2A60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Acute myelocytic leukemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.02600897; Fold-change: 0.060284347; Z-score: 0.286782876 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myeloma [ICD-11: 2A83]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Myeloma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.001455673; Fold-change: -0.593840622; Z-score: -1.657925726 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Peripheral blood | |
The Specific Disease | Myeloma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.461256759; Fold-change: 0.146970416; Z-score: 1.050452288 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Oral cancer [ICD-11: 2B6E]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Oral | |
The Specific Disease | Oral cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000269115; Fold-change: -0.561019193; Z-score: -1.197704866 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.550903291; Fold-change: -0.08797114; Z-score: -0.196617409 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Esophagal cancer [ICD-11: 2B70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Esophagus | |
The Specific Disease | Esophagal cancer | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.887382058; Fold-change: 0.157646343; Z-score: 0.391419506 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Rectal cancer [ICD-11: 2B92]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Rectal colon | |
The Specific Disease | Rectal cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.139464317; Fold-change: 0.177885709; Z-score: 0.788133101 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.137861466; Fold-change: 0.1554891; Z-score: 0.676511615 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Skin cancer [ICD-11: 2C30-2C3Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Skin cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.004111472; Fold-change: -0.020564864; Z-score: -0.045703443 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 7.43E-11; Fold-change: 0.332323397; Z-score: 0.634446245 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Renal cancer [ICD-11: 2C90-2C91]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Kidney | |
The Specific Disease | Renal cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.520480404; Fold-change: -0.26413761; Z-score: -0.666866039 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 2.77E-11; Fold-change: -0.545897606; Z-score: -0.797402761 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ureter cancer [ICD-11: 2C92]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Urothelium | |
The Specific Disease | Ureter cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.838482666; Fold-change: -0.1195786; Z-score: -0.297551839 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 20
Simpson golabi behmel syndrome [ICD-11: LD2C]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Adipose | |
The Specific Disease | Simpson golabi behmel syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.58277558; Fold-change: -0.059602929; Z-score: -0.771397697 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Tuberous sclerosis complex [ICD-11: LD2D.2]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Perituberal | |
The Specific Disease | Tuberous sclerosis complex | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.79259956; Fold-change: -0.198528833; Z-score: -1.544607995 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 3
Anemia [ICD-11: 3A00-3A9Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Anemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.25749816; Fold-change: 0.465514238; Z-score: 1.087936651 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sickle cell disease [ICD-11: 3A51.0-3A51.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Sickle cell disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.48227528; Fold-change: 0.005055487; Z-score: 0.024093353 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Thrombocythemia [ICD-11: 3B63]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Thrombocythemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.111872357; Fold-change: 0.101748331; Z-score: 0.634103547 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 4
Scleroderma [ICD-11: 4A42.Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Scleroderma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.267333413; Fold-change: 0.059695117; Z-score: 0.341757371 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sjogren syndrome [ICD-11: 4A43]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Salivary gland | |
The Specific Disease | Sjogren syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.611583385; Fold-change: 0.083163244; Z-score: 0.178554911 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.155434646; Fold-change: -0.075353723; Z-score: -0.908178014 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Behcet disease [ICD-11: 4A62]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Behcet disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.338979207; Fold-change: 0.191723474; Z-score: 0.994937896 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Autosomal dominant monocytopenia [ICD-11: 4B04]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Autosomal dominant monocytopenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.456350805; Fold-change: 0.200888398; Z-score: 0.905906176 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 5
Type 2 diabetes [ICD-11: 5A11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Type 2 diabetes | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.778571138; Fold-change: 0.06055654; Z-score: 0.158405739 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Polycystic ovary syndrome [ICD-11: 5A80.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Vastus lateralis muscle | |
The Specific Disease | Polycystic ovary syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.98450158; Fold-change: 0.044359526; Z-score: 0.239488581 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Obesity [ICD-11: 5B81]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Subcutaneous Adipose | |
The Specific Disease | Obesity | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.931473122; Fold-change: 0.009865986; Z-score: 0.073661494 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pompe disease [ICD-11: 5C51.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Biceps muscle | |
The Specific Disease | Pompe disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.913851328; Fold-change: 0.012779145; Z-score: 0.107138464 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Batten disease [ICD-11: 5C56.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Batten disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.217206241; Fold-change: 0.128885026; Z-score: 1.210939674 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 6
Autism [ICD-11: 6A02]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Autism | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.306551985; Fold-change: -0.12281283; Z-score: -0.497976518 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Anxiety disorder [ICD-11: 6B00-6B0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Anxiety disorder | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.082281287; Fold-change: 0.069715035; Z-score: 0.328480907 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 8
Parkinson disease [ICD-11: 8A00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Substantia nigra | |
The Specific Disease | Parkinson disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.616413035; Fold-change: 0.025090147; Z-score: 0.094675194 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Huntington disease [ICD-11: 8A01]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Huntington disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.484353326; Fold-change: 0.012048498; Z-score: 0.123603568 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Alzheimer disease [ICD-11: 8A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Entorhinal cortex | |
The Specific Disease | Alzheimer disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.503074942; Fold-change: -0.036331277; Z-score: -0.053768054 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Seizure [ICD-11: 8A60-8A6Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Seizure | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.567015415; Fold-change: -0.015895869; Z-score: -0.088861796 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lateral sclerosis [ICD-11: 8B60.4]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Lateral sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.048234529; Fold-change: 0.219100255; Z-score: 1.701126135 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Cervical spinal cord | |
The Specific Disease | Lateral sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.450237744; Fold-change: -0.006618677; Z-score: -0.035941645 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Muscular atrophy [ICD-11: 8C70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Muscular atrophy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.185075371; Fold-change: 0.053550705; Z-score: 0.44743947 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myopathy [ICD-11: 8C70.6]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Myopathy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.216452188; Fold-change: -0.131186875; Z-score: -0.886404213 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.